129 related articles for article (PubMed ID: 21623385)
21. Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors.
Hewedi IH; Radwan NA; Shash LS
Diagn Pathol; 2012 Jan; 7():1. PubMed ID: 22217299
[TBL] [Abstract][Full Text] [Related]
22. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.
Martin SA; Sears DL; Sebo TJ; Lohse CM; Cheville JC
Am J Surg Pathol; 2002 Mar; 26(3):292-300. PubMed ID: 11859200
[TBL] [Abstract][Full Text] [Related]
23. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
[TBL] [Abstract][Full Text] [Related]
24. Myoepithelial cells in lobular carcinoma in situ: distribution and immunophenotype.
Wang Y; Jindal S; Martel M; Wu Y; Schedin P; Troxell M
Hum Pathol; 2016 Sep; 55():126-34. PubMed ID: 27195907
[TBL] [Abstract][Full Text] [Related]
25. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
26. Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast.
Sailer V; Lüders C; Kuhn W; Pelzer V; Kristiansen G
Virchows Arch; 2015 Jul; 467(1):67-70. PubMed ID: 25850754
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
[TBL] [Abstract][Full Text] [Related]
28. Detection and diagnostic utilization of placental alkaline phosphatase in muscular tissue and tumors with myogenic differentiation.
Goldsmith JD; Pawel B; Goldblum JR; Pasha TL; Roberts S; Nelson P; Khurana JS; Barr FG; Zhang PJ
Am J Surg Pathol; 2002 Dec; 26(12):1627-33. PubMed ID: 12459630
[TBL] [Abstract][Full Text] [Related]
29. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of progesterone receptor, p16, p53 and pHH3 expression in uterine atypical leiomyoma.
Liang Y; Zhang X; Chen X; Lü W
Int J Clin Exp Pathol; 2015; 8(6):7196-202. PubMed ID: 26261614
[TBL] [Abstract][Full Text] [Related]
31. Secretory carcinoma of breast demonstrates nuclear or cytoplasmic expression in p63 immunohistochemistry.
Choi J; Kim D; Koo JS
Int J Surg Pathol; 2012 Aug; 20(4):367-72. PubMed ID: 22491513
[TBL] [Abstract][Full Text] [Related]
32. Skeletal muscle-like and rhabdoid cells in uterine leiomyomas.
Parker RL; Young RH; Clement PB
Int J Gynecol Pathol; 2005 Oct; 24(4):319-25. PubMed ID: 16175075
[TBL] [Abstract][Full Text] [Related]
33. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes.
Bishop JA; Montgomery EA; Westra WH
Am J Surg Pathol; 2014 Feb; 38(2):257-64. PubMed ID: 24418859
[TBL] [Abstract][Full Text] [Related]
34. May Sonic Hedgehog proteins be markers for malignancy in uterine smooth muscle tumors?
Garcia N; Bozzini N; Baiocchi G; da Cunha IW; Maciel GA; Soares Junior JM; Soares FA; Baracat EC; Carvalho KC
Hum Pathol; 2016 Apr; 50():43-50. PubMed ID: 26997437
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
Jeffers MD; Richmond JA; Macaulay EM
Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice.
Moore AB; He H; Yoshida A; Rico PJ; Haseman JK; Dixon D
Exp Toxicol Pathol; 2000 Jun; 52(3):195-200. PubMed ID: 10930119
[TBL] [Abstract][Full Text] [Related]
37. Quantitative measurements of desmin and vimentin immunostains and cell density in leiomyomas and leiomyosarcomas.
Remmelink M; Salmon I; Goldschmidt D; Decaestecker C; Nemec E; Berthe JV; Petein M; Pasteels JL; Kiss R
Anal Cell Pathol; 1996 Oct; 12(1):25-44. PubMed ID: 8933907
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical staining characteristics of canine gastrointestinal stromal tumors.
LaRock RG; Ginn PE
Vet Pathol; 1997 Jul; 34(4):303-11. PubMed ID: 9240839
[TBL] [Abstract][Full Text] [Related]
39. Sinonasal smooth muscle cell tumors: a clinicopathologic and immunohistochemical analysis of 12 cases with emphasis on the low-grade end of the spectrum.
Huang HY; Antonescu CR
Arch Pathol Lab Med; 2003 Mar; 127(3):297-304. PubMed ID: 12653572
[TBL] [Abstract][Full Text] [Related]
40. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
